DuPont Realigns Leadership Team to Accelerate Integrated Science Execution, Explores Strategic Alternatives for Performance

 DuPont Realigns Leadership Team to Accelerate Integrated Science Execution,
          Explores Strategic Alternatives for Performance Chemicals

PR Newswire

WILMINGTON, Del., July 23, 2013

WILMINGTON, Del., July 23, 2013 /PRNewswire/ --Taking the next steps in its
transformation to a higher growth company, DuPont today is realigning its
leadership team to accelerate its integrated science execution across the
company and is exploring strategic alternatives for its Performance Chemicals
segment. These steps are part of DuPont's transformation to a higher growth,
less cyclical company that integrates its unique scientific capabilities in
biology, chemistry and materials to develop differentiated, high-value
solutions in the attractive agriculture and nutrition, industrial biosciences
and advanced materials markets worldwide.

To accelerate the execution of its applied integrated science strategy across
its businesses, James C. Collins, Jr., who currently leads the Industrial
Biosciences business, will become senior vice president, reporting to DuPont
Chair and CEO Ellen Kullman, and will oversee the Industrial Biosciences,
Performance Polymers and Packaging & Industrial Polymers businesses. Collins
will accelerate the integration of DuPont's rapidly growing and leading
industrial biotechnology into its wide-ranging advanced materials businesses,
as demand for renewably sourced materials expands steadily. A 29-year veteran
of DuPont, Collins led the Danisco acquisition integration team before
assuming his current role.

In addition, Matthew L. Trerotola will rejoin DuPont and report to Kullman as
senior vice president with responsibility for the Protection Technologies,
Building Innovations, and Sustainable Solutions businesses. He will be
accountable for driving improved execution and accelerate growth in these
businesses. A previous DuPont corporate officer, Trerotola is familiar with
DuPont's strong brands including DuPont™ Kevlar®, Tyvek® and Nomex®. Most
recently, he was vice president and group executive of life sciences for the
Danaher Corporation.

DuPont's consideration of strategic alternatives for its Performance Chemical
segment may include a full or partial separation of each of these businesses
from the company through a spin-off, sale or other transaction. The segment
includes Titanium Technologies and Chemicals & Fluoroproducts businesses which
generated total sales of $7.2 billion in 2012. DuPont may pursue a different
strategic alternative for each business.

DuPont's decision to explore strategic alternatives for its Performance
Chemicals businesses reflects its ongoing portfolio review to determine how
best integrated science can contribute to growth and the optimal mix of
businesses for maximizing shareholder value. This follows DuPont's sale of
its Performance Coatings business earlier this year and the acquisition of
Danisco in 2011.

"As we discussed at our Investors Day in May, we have been carefully weighing
the strong cash generation of our Performance Chemicals businesses against
their cyclicality and lower growth profile, as well as where the power of
DuPont's integrated science can be differentiated," said Kullman. "We are
evaluating options for our Performance Chemicals businesses as part of our
ongoing plan to deliver higher growth and greater value creation for our

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802. The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such
global challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment. For additional information about DuPont and its commitment to
inclusive innovation, please visit 

Forward Looking Statements
This news release contains forward-looking statements which may be identified
by their use of words like "plans," "expects," "will," "anticipates,"
"believes," "intends," "estimates," "anticipates" or other words of similar
meaning. All statements that address expectations or projections about the
future are forward-looking statements. Forward-looking statements are not
guarantees of future performance and are based on certain assumptions and
expectations of future events which may not be realized. Forward-looking
statements also involve a risks and uncertainties, many of which are beyond
the company's control. . Some of the important factors that could cause the
company's actual results to differ materially from those projected in any such
forward-looking statements are: fluctuations in energy and raw material
prices; failure to develop and market new products and optimally manage
product life cycles; significant litigation and environmental matters;
failure to appropriately manage process safety and product stewardship
issues; changes in laws and regulations or political conditions; global
economic and capital markets conditions; such as inflation, interest and
currency exchange rates; business or supply disruptions; security threats,
such as acts of sabotage, terrorism or war, weather events and natural
disasters; in ability to protect and enforce the company's intellectual
property rights; and successful integration of acquired business and
divestitures of underperforming or non-strategic assets. Further description
of risks and uncertainties can be found in DuPont's annual and quarterly
reports. The Company does not undertake to update any forward-looking
statements as a result of future developments or new information.


The DuPont Oval Logo, DuPont™, The miracles of science™, Kevlar®, Tyvek® and
Nomex® are registered trademarks or trademarks of DuPont or its affiliates.


Contact: Michael Hanretta, 302-774-4005,
Press spacebar to pause and continue. Press esc to stop.